Back

Low risk obese patient with persistently elevated mean LDL-C =141 mg/dl, who is not willing to use statins. To treat or not to treat? - discussion

16 April 2021 (10:00 - 10:15)
Organised by:
Congress Presentation Part of: Clinical cases session - Primary care and risk factor management Risk Factors and Prevention EAPC Premium Access ESC Preventive Cardiology 2021

1 More presentation in this session

Presentation thumbnail
Low risk obese patient with persistently elevated mean LDL-C =141 mg/dl, who is not willing to use statins. To treat or not to treat?
Associate Professor A. Cicero (Bologna, IT)

Access the full session

Session thumbnail
Clinical cases session - Primary care and risk factor management
Video

The Event

Event poster

ESC Preventive Cardiology 2021

16 April 2021 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Lipid lowering in an elderly patient: how low should we go? – case presentation
14 April 2023
thumbnail
Congress Presentation
Discordance between LDL cholesterol and apolypoprotein B. Which to prefer to guide treatment?
13 April 2023
thumbnail
Congress Presentation
Association of body mass index with non-achievement of target low-density lipoprotein level in older patients at very high cardiovascular risk: a multicentre study
27 August 2021
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources